Oxidized thymosin beta 4

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01) C07K 14/575 (2006.01)

Patent

CA 2325984

The present invention relates to use of oxidised thymosin .beta.4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response or septic shock. The present invention also provides pharmaceutical formulations comprising oxidised thymosin .beta.4 together with a suitable excipient.

Utilisation de thymosine .beta.4 oxydée en thérapie, plus particulièrement dans le traitement de maladies ou états pathologiques associés à une réponse inflammatoire ou un choc septique. La présente invention concerne également des compositions pharmaceutiques contenant de la thymosine .beta.4 oxydée ainsi qu'un excipient approprié.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oxidized thymosin beta 4 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxidized thymosin beta 4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidized thymosin beta 4 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1900585

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.